Author
Marisa Lopez‐Cruzan
- Indexed works
- 6
- Total citations
- 478
- Active years
- 5
Collaborators
Works in the record
Nature Medicine 2023
Preprint · OA
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
Aging Cell 2021
Open access · CC-BY
17‐a‐estradiol late in life extends lifespan in aging UM‐HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex
Aging Cell 2022
Open access · CC-BY
Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice
Research Square 2023
Preprint · CC-BY
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Neurotherapeutics 2025
Open access · CC-BY
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease
Research Square 2024
Preprint · CC-BY